Skip to main content
Alan Lichtenstein, MD, Hematology, Los Angeles, CA, Greater Los Angeles HCS

AlanKivaLichtensteinMD

Hematology • Los Angeles, CA

Professor, Medicine, UCLA School of Medicine

Join to view full profile

Dr. Lichtenstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lichtenstein's full profile

Already have an account?

Education & Training

  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1977 - 1978
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1975 - 1977
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1972 - 1975
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1975 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo
    Alan Lichtenstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Grant Support

  • Regulation Of C-MYC Translation By Hnrnp A1: Role In Multiple Myeloma Tumor RespoNational Cancer Institute2009–2011
  • Use Of CCI-779 In Multiple MyelomaNational Cancer Institute2008–2009
  • Sensitivity Multiple Myeloma Cells To Mtor InhibitorsNational Cancer Institute2005–2009
  • EBV Lytic Re-Activation In Nasopharyngeal CarcinomaNational Cancer Institute2005–2006
  • The Akt-Mtor Pathway In Multiple MyelomaNational Cancer Institute2002–2005
  • Anti-Tumor Properties Of Acute InflammationNational Cancer Institute1985–1987

Hospital Affiliations

Dr. Alan Lichtenstein, Dr. Alan Lichtenstein, MD, Dr. A Lichtenstein, Dr. Alan Kiva Lichtenstein